We are live on ! Find out more
MM

Mason Morfit ValueAct Holdings

AUM $5.63B
1-Year Est. Return 5.11%
 

Mason Morfit is chief executive officer of ValueAct Capital, a major constructive-activist investment firm. ValueAct typically takes significant stakes in companies and works with boards on strategy, capital allocation, and operational improvement. Morfit’s campaigns and holdings are closely watched in both activist and fundamental investing communities.

This Fund
S&P 500
This Quarter Est. Return
-22.09%
1 Year Est. Return
-5.11%
3 Year Est. Return
+78.71%
5 Year Est. Return
+99.09%
10 Year Est. Return
+739.59%
AUM
$8.03B
AUM Growth
-$2.14B
Cap. Flow
+$256M
Cap. Flow %
3.19%
Top 10 Hldgs %
94.86%
Holding
23
New
4
Increased
11
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$336M
2
MS icon
Morgan Stanley
MS
+$236M
3
ACA icon
Arcosa
ACA
+$196M
4
STX icon
Seagate
STX
+$37.8M
5
KKR icon
KKR & Co
KKR
+$22.9M

Sector Composition

Rank Sector Weight
1 Financials 59.58%
2 Technology 13.12%
3 Industrials 10.13%
4 Real Estate 9.93%
5 Healthcare 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
1
Citigroup
C
$221B
$1.64B 20.44%
31,525,500
+5,300,000
+20% +$336M
STX icon
2
Seagate
STX
$193B
$1.05B 13.12%
27,295,160
+898,595
+3% +$37.8M
MS icon
3
Morgan Stanley
MS
$336B
$1.04B 12.95%
26,228,561
+5,418,091
+26% +$236M
KKR icon
4
KKR & Co
KKR
$97.4B
$995M 12.4%
50,700,000
+1,000,000
+2% +$22.9M
CBRE icon
5
CBRE Group
CBRE
$44B
$798M 9.93%
19,921,376
+4,453
+0% +$184K
BFH icon
6
Bread Financial
BFH
$4.07B
$782M 9.73%
6,525,180
-1,096,375
-14% -$172M
TRN icon
7
Trinity Industries
TRN
$2.37B
$451M 5.62%
21,900,000
-7,835,561
-26% -$181M
BHC icon
8
Bausch Health
BHC
$2.41B
$333M 4.15%
18,033,149
SLM icon
9
SLM Corp
SLM
$4.97B
$326M 4.06%
39,184,254
ACA icon
10
Arcosa
ACA
$7.12B
$198M 2.46%
+7,135,963
New +$196M
AWI icon
11
Armstrong World Industries
AWI
$7.55B
$131M 1.63%
2,244,910
-2,980,000
-57% -$190M
HE icon
12
Hawaiian Electric Industries
HE
$1.99B
$55.2M 0.69%
1,507,295
+310,034
+26% +$11.5M
AFI
13
DELISTED
Armstrong Flooring, Inc.
AFI
$54.6M 0.68%
4,614,787
STRA icon
14
Strategic Education
STRA
$1.85B
$45.9M 0.57%
404,741
+162,600
+67% +$20.7M
LIND icon
15
Lindblad Expeditions
LIND
$2.04B
$31M 0.39%
2,300,572
+609,272
+36% +$8.13M
UFI icon
16
UNIFI
UFI
$149M
$25.8M 0.32%
1,127,679
+202,679
+22% +$5.12M
AES icon
17
AES
AES
$10.5B
$22.6M 0.28%
1,564,500
+35,000
+2% +$526K
EVA
18
DELISTED
Enviva Inc.
EVA
$20.1M 0.25%
723,650
+31,621
+5% +$936K
DAR icon
19
Darling Ingredients
DAR
$10.4B
$13.1M 0.16%
+180,328
New +$3.66M
ARMK icon
20
Aramark
ARMK
$15.8B
$9.54M 0.12%
+317,484
New +$8.24M
BE icon
21
Bloom Energy
BE
$59.3B
$4.49M 0.06%
+250,000
New +$4.83M
GEN icon
22
Gen Digital
GEN
$17.3B
-500,000
Closed -$10.6M
XRAY icon
23
Dentsply Sirona
XRAY
$2.18B
-2,200,000
Closed -$83M

Similar funds

Mason Morfit's Q4 2018 Portfolio in Review

As of Q4 2018, Mason Morfit held 23 positions worth $8.03B, down 21% from $10.2B the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Mason Morfit deployed $256M of net new capital in Q4 2018, opening 4 new positions and adding to 11 existing holdings. Its largest new stake was Arcosa: 7,135,963 shares worth $198M.

By sector, the portfolio is most concentrated in Financials at 60% of assets, down from 60% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Armstrong World Industries, an estimated $190M trimmed.

  • Mason Morfit's largest Q4 2018 buy was Arcosa: 7,135,963 shares worth $198M.
  • Mason Morfit added most to Citigroup in Q4 2018, an estimated $336M increase.
  • Mason Morfit's biggest Q4 2018 reduction was Armstrong World Industries, cutting an estimated $190M.
  • Mason Morfit fully exited Dentsply Sirona in Q4 2018, selling an estimated $83M.
  • Mason Morfit's ten largest holdings make up 95% of its $8.03B portfolio in Q4 2018.
  • Mason Morfit opened 4 new positions and closed 2 in Q4 2018.
  • Mason Morfit's portfolio value fell 21% quarter-over-quarter to $8.03B.

Based on ValueAct Holdings's 13F filing for Q4 2018, filed 14 Feb 2019.